Skip to main content

Advertisement

Table 1 Baseline characteristics in patients with chronic kidney disease and controls

From: Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro

Baseline characteristics Controls CKD P-value
  N = 19 N = 23  
Age, y (IQR) 62 (48-71) 78 (64-83) 0.043
Male, n (%) 13 (68.4) 15 (65.2) 0.755
Hemoglobin, mmol/L (IQR) 9.4 (9.0-9.9) 7.2 (6.7-7.8) 0.006
Hematocrit, L/L (IQR) 0.44 (0.43-0.47) 0.36 (0.34-0.38) 0.001
Platelet count, 109/L (IQR) 210 (150-240) 187 (160-225) 0.223
Hemodialysis, n (%) NA 14 (60.9) -
Cardiorenal syndrome, n (%) NA 9 (39.1) -
EPO use, n (%) NA 5 (21.7) -
Aspirin use, n (%) 0 11 (47.8) -
  1. CKD chronic kidney disease, IQR inter quartile range, EPO erythropoietin.